<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33439438</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1182</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>Molecular neurobiology</Title><ISOAbbreviation>Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Myeloid TBK1 Deficiency Induces Motor Deficits and Axon Degeneration Through Inflammatory Cell Infiltration.</ArticleTitle><Pagination><StartPage>2435</StartPage><EndPage>2446</EndPage><MedlinePgn>2435-2446</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-020-02235-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">TANK-binding kinase1 (TBK1) haploinsufficiency has been shown to cause both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD); however, the mechanism is unclear.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Myeloid Tbk1 knockout mice (Tbk1-LKO mice) were established and motor function and pathological analyses were also performed. The level of p-TBK1 was analyzed in the ALS animal model and in patient samples using flow cytometry. The expression of inflammatory proteins and mRNAs was analyzed via western blotting and RT-PCR, respectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The latency to fall in seven-month-old Tbk1-LKO mice was significantly reduced in evaluations conducted on two consecutive days. Overall, 25.6% of Tbk1-LKO mice presented paralysis symptoms and signs, along with a loosened myelin sheath and axon degeneration at 14-16 months of age. Furthermore, the Tbk1 deficiency in myeloid cells induced inflammatory cell infiltration and dysbacteriosis in the digestive tract. Additionally, p-TBK1 levels were reduced by 29.5% and 14.8% in monocytes of patients with definite ALS and probable ALS and decreased by 27.6% and 45.5% in monocytes and microglia of ALS animals, respectively. The use of PEI-mannose-TBK1 or PEI-mannose-SaCas9-sgRNA to delete mutant SOD1 in macrophages significantly delayed disease onset and prolonged survival in the mouse model of ALS.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Based on these data, inflammatory monocyte and macrophage infiltration and impaired innate immune defenses contribute to ALS and FTD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Weisong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, Shijiazhuang, Hebei, 050000, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cardiocerebrovascular Disease, Shijiazhuang, Hebei, 050000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Le</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Yunyun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Huai-Peng</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Shijiazhuang Pingan Hospital, Shijiazhuang, Hebei, 050021, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhongyao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bi</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Moran</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yakun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yanqin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Jiangsu Nhwa Pharmaceutical Co. Ltd., Xuzhou, Jiangsu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Xueqin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yaling</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, Shijiazhuang, Hebei, 050000, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cardiocerebrovascular Disease, Shijiazhuang, Hebei, 050000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chunyan</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6214-9730</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People's Republic of China. hebeichunyanli@aliyun.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, Shijiazhuang, Hebei, 050000, People's Republic of China. hebeichunyanli@aliyun.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cardiocerebrovascular Disease, Shijiazhuang, Hebei, 050000, People's Republic of China. hebeichunyanli@aliyun.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>31371089</GrantID><Agency>Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>81171210</GrantID><Agency>Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Neurobiol</MedlineTA><NlmUniqueID>8900963</NlmUniqueID><ISSNLinking>0893-7648</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.1.-</RegistryNumber><NameOfSubstance UI="C498588">Tbk1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009043" MajorTopicYN="N">Motor Activity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Macrophage</Keyword><Keyword MajorTopicYN="N">Tbk1</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>13</Day><Hour>12</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33439438</ArticleId><ArticleId IdType="doi">10.1007/s12035-020-02235-3</ArticleId><ArticleId IdType="pii">10.1007/s12035-020-02235-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor JP, Brown RH Jr, Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nature 539:197&#x2013;206</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Appel SH (2019) Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol 18(2):211&#x2013;220</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30394-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, Couthouis J, Lu YF et al (2015) Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 347(6229):1436&#x2013;1441</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, M&#xfc;ller K, Marroquin N, Nordin F et al (2015) Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci 18(5):631&#x2013;636</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, M&#xfc;ller K, Ludolph AC, Weishaupt JH, Andersen PM (2017) Association of mutations in TBK1 with sporadic and familial amyotrophic lateral sclerosis and frontotemporal dementia. JAMA Neurol 74(1):110&#x2013;113</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.3712</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomen-Hoerth C, Anderson T, Miller B (2002) The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology. 59(7):1077&#x2013;1079</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.59.7.1077</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Zee J, Gijselinck I, Van Mossevelde S, Perrone F, Dillen L, Heeman B, B&#xe4;umer V, Engelborghs S et al (2017) TBK1 mutation spectrum in an extended European patient cohort with frontotemporal dementia and amyotrophic lateral sclerosis. Hum Mutat 38(3):297&#x2013;309</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.23161</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchlik E, Thakker P, Carlson T, Jiang Z, Ryan M, Marusic S, Goutagny N, Kuang W et al (2010 Dec) Mice lacking Tbk1 activity exhibit immune cell infiltrates in multiple tissues and increased susceptibility to LPS-induced lethality. J Leukoc Biol 88(6):1171&#x2013;1180</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0210071</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S, ten Oever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J (2003) Triggering the interferon antiviral response through an IKK-related pathway. Science. 300(5622):1148&#x2013;1151</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1081315</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao P, Wong KI, Sun X, Reilly SM, Uhm M, Liao Z, Skorobogatko Y, Saltiel AR (2018) TBK1 at the crossroads of inflammation and energy homeostasis in adipose tissue. Cell. 172(4):731&#x2013;743</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.01.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;oz MC, Giani JF, Mayer MA, Toblli JE, Turyn D, Dominici FP (2009) TANK-binding kinase 1 mediates phosphorylation of insulin receptor at serine residue 994: a potential link between inflammation and insulin resistance. J Endocrinol 201(2):185&#x2013;197</Citation><ArticleIdList><ArticleId IdType="doi">10.1677/JOE-08-0276</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnard M, Mirtsos C, Suzuki S, Graham K, Huang J, Ng M, Iti&#xe9; A, Wakeham A et al (2000) Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J 19(18):4976&#x2013;4985</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/19.18.4976</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J, Xiao Y, Chang JH, Yu J, Hu H, Starr R, Brittain GC, Chang M et al (2012) The kinase TBK1 controls IgA class switching by negatively regulating noncanonical NF-&#x3ba;B signaling. Nat Immunol 13(11):1101&#x2013;1109</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2423</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, Zhou X, Chang M, Nakaya M, Chang JH, Xiao Y, Lindsey JW, Dorta-Estremera S et al (2015) Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation. Nat Commun 6:6074</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7074</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y, Zou Q, Xie X, Liu T, Li HS, Jie Z, Jin J, Hu H et al (2017) The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity. J Exp Med 214(5):1493&#x2013;1507</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20161524</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D, Jin T, Zhu H, Chen H, Ofengeim D, Zou C, Mifflin L, Pan L et al (2018) TBK1 suppresses RIPK1-driven apoptosis and inflammation during development and in aging. Cell 174(6):1477&#x2013;1491</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.07.041</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley ME, Baloh RH (2019) Inflammation in ALS/FTD pathogenesis. Acta Neuropathol 137(5):715&#x2013;730</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1933-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu CH, Allen K, Oei F, Leoni E, Kuhle J, Tree T, Fratta P, Sharma N et al (2016) Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm 3(4):e244</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000244</ArticleId></ArticleIdList></Reference><Reference><Citation>Sj&#xf6;gren M, Folkesson S, Blennow K, Tarkowski E (2004) Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications. J Neurol Neurosurg Psychiatry 75(8):1107&#x2013;1111</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2003.019422</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS, Engelhardt JI, Sikl&#xf3;s L, Simpson EP, Kim SH, Pan T, Goodman JC, Siddique T et al (2004) Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 55(2):221&#x2013;235</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10805</ArticleId></ArticleIdList></Reference><Reference><Citation>Lall D, Baloh RH (2017) Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia. J Clin Invest 127(9):3250&#x2013;3258</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI90607</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyon MS, Wosiski-Kuhn M, Gillespie R, Caress J, Milligan C (2019) Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiol Pathol Muscle Nerve 59(1):10&#x2013;22</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26289</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan W, Guo M, Yi L, Liu Y, Li Z, Ma Y, Zhang G, Liu Y et al (2020) The deletion of mutant SOD1 via CRISPR/Cas9/sgRNA prolongs survival in an amyotrophic lateral sclerosis mouse model. Gene Ther 27(3-4):157&#x2013;169</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41434-019-0116-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan W, Guo M, Yi L, Zhang J, Bi Y, Liu Y, Li Y, Li Z et al (2019) Deletion of Tbk1 disrupts autophagy and reproduces behavioral and locomotor symptoms of FTD-ALS in mice. Aging (Albany NY) 11(8):2457&#x2013;2476</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101936</ArticleId></ArticleIdList></Reference><Reference><Citation>Segura-Anaya E, Flores-Miranda R, Mart&#xed;nez-G&#xf3;mez A, Dent MAR (2018) A novel histochemical method of simultaneous detection by a single- or double-immunofluorescence and Bielschowsky&#x2019;s silver staining in teased rat sciatic nerves. J Neurosci Methods 304:46&#x2013;51</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneumeth.2018.03.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I, Van Mossevelde S, van der Zee J, Sieben A, Philtjens S, Heeman B, Engelborghs S, Vandenbulcke M et al (2015) Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort. Neurology. 85(24):2116&#x2013;2125</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002220</ArticleId></ArticleIdList></Reference><Reference><Citation>Conforti L, Gilley J, Coleman MP (2014) Wallerian degeneration: an emerging axon death pathway linking injury and disease. Nat Rev Neurosci 15:394&#x2013;409</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3680</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y, Ofengeim D, Najafov A, Das S, Saberi S, Li Y, Hitomi J, Zhu H et al (2016) RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science. 353(6299):603&#x2013;608</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6803</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D, Sieverding K, Bruno C, Luningschror P, Buck E, Mungwa S, Fischer L, Brockmann SJ et al (2019) Heterozygous TBK1 loss has opposing effects in early and late stages of ALS in mice. J Exp Med 216(2):267&#x2013;278</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20180729</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes AE, Ferraiuolo L, Haidet-Phillips AM, Schmelzer L, Braun L, Miranda CJ, Ladner KJ, Bevan AK et al (2014) Microglia induce motor neuron death via the classical NF-&#x3ba;B pathway in amyotrophic lateral sclerosis. Neuron. 81(5):1009&#x2013;1023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A, Wells MF, Limone F, Couto A, Smith KS, Keaney J, Gillet G, van Gastel N et al (2020) C9ORF72 suppresses systemic and neural inflammation induced by gut bacteria. Nature. 582(7810):89&#x2013;94</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2288-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U, Dori-Bachash M, Kleimeyer C, Moresi C et al (2019) Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 572(7770):474&#x2013;480</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1443-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Yi J, Zhang YG, Zhou J, Sun J (2015) Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Phys Rep 3(4):e12356</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.12356</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao G, Harhaj EW, Sun SC (2001) NF-&#x3ba;B-inducing kinase regulates the processing of NF-&#x3ba;B2 p100. Mol Cell 7(2):401&#x2013;409</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(01)00187-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun SC (2017) The non-canonical NF-&#x3ba;B pathway in immunity and inflammation. Nat Rev Immunol 17(9):545&#x2013;558</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.52</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi JH, Xie X, Sun SC (2018) TBK1 as a regulator of autoimmunity and antitumor immunity. Cell Mol Immunol 15(8):743&#x2013;745</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2017.165</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>